Multiple system atrophy (MSA) is a rare adult-onset neurodegenerative disease of unknown cause, with no effective therapeutic options, and no cure. Limited work to date has attempted to characterize the transcriptional changes associated with the disease, which presents as either predominating parkinsonian (MSA-P) or cerebellar (MSC-C) symptoms. We report here the results of RNA expression profiling of cerebellar white matter (CWM) tissue from two independent cohorts of MSA patients (n=66) and healthy controls (HC; n=66). RNA samples from bulk brain tissue and from oligodendrocytes obtained by laser capture microdissection (LCM) were sequenced. Differentially expressed genes (DEGs) were obtained and were examined before and after stratifying by MSA clinical sub-type.
Introduction
Multiple-system atrophy (MSA) is a rare neurodegenerative disorder characterized by autonomic dysfunction, ataxia, and parkinsonism. The prevalence is estimated to be between 1.9 to 4.9 per 100,000 (Bhidayasiri and Ling, 2008; Stefanova et al., 2009 ). The disease affects both sexes equally with onset typically in the sixth decade of life and with an average survival after diagnosis of less than ten years [53] . There are no effective long-term therapeutic options for the MSA patient, and no cure.
MSA as a unifying diagnostic terminology was developed to encapsulate three neurological entities: striatonigral degeneration, olivopontocerebellar atrophy, and ShyDrager syndrome (Goedert, 2001 ; Quinn and Wenning, 1995; Vanacore, 2005;  Wakabayashi et al., 1998). Two different clinical subtypes have been described based on the predominating motor features noted during the early stages of the disease: the MSA-P subtype (dominated by parkinsonism) and the MSA-C subtype (dominated by cerebellar ataxia). However, in the later stages of the disease, the phenotypic characteristics of both subtypes are typically noted in the patient [16] . A definitive diagnosis of MSA is GCIs are primarily comprised of aggregated α-synuclein, therefore MSA can be classified as an oligodendroglial α-synucleinopathy, which is a point of distinction compared to neuronal α-synucleinopathies like Parkinson's disease. Interestingly, work investigating the earliest molecular changes associated with MSA has suggested that oligodendrocyte intracellular accumulation of p25α, a protein associated with myelination, may be altered before α -synuclein aggregation is observed [53] . The aggregation of α-synuclein is thought to lead to a disruption of the role of the oligodendrocyte in the process of neuronal myelination leading to microglial activation and subsequent release of mis-folded α-synuclein by the increasingly dysfunctional oligodendrocytes. Neighboring neurons may uptake this extracellular α-synuclein and it could thereby initiate new aggregation inside the neuronal cell. Additionally, the toxic α-synuclein species may spread to neurons in other synaptically-connected brain regions in a prion-like fashion. The lack of effective oligodendrocyte support for the local neurons, and the neuronal effects of the α-synuclein inclusions, eventually results in axonal dysfunction, neuronal cell death, and a reactive astrogliosis [16] .
The cause of MSA is not known, however it is generally believed to be sporadic.
Several genomic studies have been performed to shed light on the molecular pathogenesis of the disease. Three SNPs located in the α -synuclein gene (SCNA) have been associated with the risk of developing MSA [48] . In an independent study conducted by evaluating 32 SNPs in the SNCA gene, one SNP associated with MSA and one haplotype associated with the MSA-C subgroup were noted [2] . Whole genome sequencing analysis identified COQ2 genetic variants associated with both sporadic and familial MSA [37] . However, this finding has not been replicated in other cohorts [49] . In another GWAS, including MSA patients and healthy controls, several SNPs located in different genes (FBX047, ELOVL7, EDN1, and MAPT) were found to be potentially associated, but were not significant after multiple test correction [47] . Finally, the presence of an expansion of one allele in SCA3 (a gene associated with spinocerebellar ataxia) was observed in a patient
showing clinical features consistent with MSA-C [38] . Recently, epigenetic modifications, such as DNA methylation changes, have also been identified in neurodegenerative diseases. A recent study reported white matter tissue DNA methylation changes associated with MSA, including changes in HIP1, LMAN2 and MOBP [8] .
Three different gene expression profiling studies conducted on neuropathologically verified human brain samples have been reported to date. The first study [35] utilized transcriptome profiling by RNA-sequencing of the white and grey matter of the frontal cortex from 6 MSA patients and 6 controls. In the grey matter they detected 5 genes differentially expressed (HLA-A, HLA-B, HLA-C, TTR and LOC389831). In the white matter they identified 7 genes, including the 3 HLA genes detected in the grey matter. The additional genes were: HBA1, HBA2, HBB and IL1RL1.
The SNCA gene was detected to be upregulated in both comparisons but it was not statistically significant. They also compared the white matter versus the grey matter in patients, detecting a total of 1,910 differentially expressed genes. A second study was conducted using the same 12 samples, but using strand-specific RNA-sequencing [36] , detecting a total of 123 differentially expressed genes. Most detected genes were lincRNAs or un-annotated transcripts. Some of the genes found in the previous study [35] were confirmed; HBB, IL1RL1, TTR and LOC389831. Finally, a study determining the differential expression of circular RNA (circRNA) in the MSA frontal cortex was conducted [12] , identifying 5 circRNAs produced by backsplicing of the precursor mRNAs from the IQCK, EFCAB11, DTNA, MAP4K3, and MCTP1 genetic loci. No other RNA sequencing studies have been conducted thus far.
In this study we utilized RNA sequencing to characterize the cerebellar white matter transcriptome from neuropathologically verified MSA cases and controls using two independent sample sets and two different profiling technologies.
Material and methods
Extended methods are reported in the Supplementary Appendix
Human samples
We analyzed two independent cohorts of postmortem cerebellar white matter (CWM)
that included both MSA-P and MSA-C subtypes. (Table 1B) .
RNA extraction and RNA sequencing
For C1, total DNAse-treated RNA was extracted using the Qiagen RNAeasy kit (Qiagen). 
Quality was assessed by Bioanalyzer (Agilent

Laser Capture Microdissection (LCM)
Twelve samples (6 MSA, 6 HC) from C1 were used for laser capture microdissection (LCM) of oligodendrocytes from cerebellar white matter (Ordway et al., 2009 ).
Oligodendrocytes were stained by using a modified H&E staining protocol adapted from
Ordway et al. [39] . A total of 300 oligodendrocytes per sample were captured using Arcturus CapSure Macro LCM Caps (Applied Biosystems) with the following settings:
UV speed at 676 um/s and UV current at 2%. RNA was extracted immediately after cell capture using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems). For library preparation the SMARTer® Stranded Total RNA-Seq Kit -Pico Input (Clontech/Takara) was used. Samples were sequenced (2 x 75 bp paired-end run) on the Illumina HiSeq2500.
Data Analysis
Quality controls on FASTQ files were conducted using MultiQC software v0.9 [22] . The reads were aligned to the human reference genome (GRCh37) using the STAR software v2.5 [20] and summarized as gene-level counts using featureCounts 1.4.4 [32] . For both datasets (C1 and C2) PCA analysis was used to assess the presence of outliers and to detect any batch effects. Four samples were deemed to be outliers and were removed (detailed below in Results). Gene expression differential analyses between MSA cases and HC were conducted using the R package DESeq2 v1.14. The results from the two cohorts were combined using a meta-analysis approach based on the weighted-Z method [62] as implemented in the R-package survcomp [50] 
Cell specific Expression
We classified the genes detected in the differential expression analysis using an external database of expression values from different types of cells isolated from mouse cerebral cortex [63] . We computed an enrichment score for each cell type and gene, assigning each gene to a specific cell type according to the relative expression in the other cell types. The enrichment of cell specific genes was investigated across DEGs and coexpression modules using a hypergeometric statistic (R function phyper).
Enrichment and functional Network analysis
Lists of DEGs were analyzed for Gene Ontology (GO) enrichment using the R-package 
Weighted Correlation Network Analysis
We conducted Weighted Correlation Network Analysis (WGCNA) in the MSA-C cohorts with the aim of identifying modules of co-expressed genes associated with the disease and enriched for specific biological processes [31] . We computed the co-expression networks using the data from C1 and then we estimated the module preservation in C2, using only MSA-C and HC. The analysis was conducted using the WGCNA R-package
[31]. Genes for both C1 and C2 with less than 10 average counts were filtered out due to low expression and data were normalized using the vst function of the DESeq2 package [33] . The matrix of expression values was adjusted for age, sex, source and PMI using the function removeBatchEffect as implemented in the limma R-package [45] . Finally, we filtered out the 50% of genes having lower Median Absolute Deviation (MAD). We generated a signed co-expression network for C1 using the function blockwiseModules, with the option mergeCutHeight = 0.25. Then, we computed the module eigengenes and we investigated their relationship with disease status using a linear model as implemented in the limma package. We calculated the module membership and gene-trait significance (MSA-C disease status) with the goal of ranking genes in each co-expression modules.
Modules associated with disease status were further investigated using GO enrichment analysis. The enrichment for genes expressed in specific cell types was conducted using as reference gene sets the gene specifically expressed in the 5 cell types from Zhang et al. [63] and test sets including all of the genes ranked by module memberships for the module associated with the disease status. Finally, we checked the module preservation in C2 using the modulePreservation function with 1,000 permutations. Relevant coexpression networks were exported and visualized using Cytoscape v3.7.2 [51] .
Results
Quality controls
For and NFIL3 (adj p < 0.01; all upregulated). In the MSA-P clinical sub-type we detected only one DEG (GPNMB), whereas in MSA-C the top genes were: PGAM2, ST5, STON1, RFTN1, ACTN1 and MMP14 (adj p < 1.0E-04; all upregulated) ( Table 2 ; Fig. 2 ). We explored the differential expression between SND vs HC, and OPCA vs HC, detecting a total of 7 and 58 genes, respectively. MLPH, detected in SND, was also detected when analyzing the clinical subtype MSA-P in C2, whereas a total of 47 genes detected in OPCA were also observed in the MSA-C clinical subtype in C2 (Table S7 ; Fig. S6 ).
Correlation of the log2 FC between the differential analysis for clinical and neuropathological classification criteria were ρ = 0.622 (MSA-P/SND) and ρ = 0.830 (both p < 2.2E-16) (Fig. S7 ).
We explored the functional significance of the DEGs by applying a functional network analysis specific for the cerebellum and a GO enrichment analysis. Using the 35
MSA DEGs (Table S4) we detected a small network with 2 modules enriched for "cellcell adhesion" (SELL and BCL6 genes) and "angiogenesis" (COL4A1 and COL4A2 genes) (both q < 0.01) (Fig. S8 ). The GO analysis yielded significant enrichment of the Biological Process "collagen-activated signaling pathway" (adj p = 0.030; genes:
COL4A1, COL4A2, ITGA11).
Using all of the 747 MSA-C DEGs (Table S6) we detected a large network including 9 different modules ( Fig. 3) . We observed the highest enrichment significance in module 1 (M1) which was amyloid-β metabolism (top GO process: q = 5.3E-05, S9 ). The second highest significance was reached in module 2 (M2) for respiratory chain complex assembly (top GO process: q = 8.2E-03) ( Table 3, Table S8 ). With the GO analysis we detected 625 significant functional classes, mostly related to cellular and cytoplasmatic components, neuro and gliogenesis (Fig. S10) .
Enrichment of AD genes in MSA-C
After we observed the presence of the AD-related process (amyloid-β metabolism) and genes in MSA-C, we tested the enrichment of AD genes in MSA-C. We used data from AMP-AD, running an enrichment analysis by brain region using as reference sets the DEGs from each brain region. The results showed a significant enrichment of TCX (adj p = 7.4E-05) and PHG (adj p = 2.0E-02) AD DEGs among upregulated MSA-C genes (Fig. S11) which were also confirmed when we used more conservative cutoffs to select AD genes (adj p < 0.01, < 0.001, and < 0.0001) ( Table S9A) . As further validation, we used the less variable genes between AD and non-demented controls (ND) (adj p > 0.950). As expected, we did not observe any significant enrichment of TCX or PHG AD DEGs genes (Table S9B) . We compared the DEGs detected in MSA-C, with the DEGs detected in TCX and PHG, only selecting genes having the same log2 FC direction, considering the comparison: affected vs non-affected. We detected 201 genes in TCX, 152 in PHG and 103 common between both regions TCX, PHG and MSA-C (Table S10) .
Differential expression in LCM oligodendrocytes
We detected a total of 187 differentially expressed genes in oligodendrocytes (90 upregulated and 97 downregulated) (Fig. 1D) . Details for the complete list of genes are reported in Table S11 . The top 4 significant genes (adj p < 1.0E-05) were: GGCX, MOCS1, NF1 and LINC01572 (Table 4) . Using the functional module discovery analysis we detected a network including 4 modules (72 genes in total) enriched for telomere maintenance (M1: q = 1.9E-03; genes: PTGES3 and WRAP53) and ncRNA processing (M2: q = 0.0025; genes: DIMT1, INTS8, and MTREX). Modules 3 and 4 are weakly enriched for immune processes and cell growth (q < 0.05) (Fig. S12) . Using the GO analysis in the complete gene list, we detected a significant enrichment in the myelination process mostly due to downregulated genes (Fig. S13) .
Bioinformatic-based cell specific expression profiling
We classified the DEGs obtained in the MSA-C group according to their expression in five brain cell types [63] . We selected only the MSA-C results because the large number of DEGs makes it possible to identify robust cell-specific upregulation/downregulation trends. Most of the DEGs were not cell specific ("mixed": 74.7% of the total DEGs), whereas the remaining genes were: astrocyte (6.6%), oligodendrocyte (5.8%), endothelial cell (5.1%), neuron (4.1%) and microglia (3.7%) specific. We found a significant overrepresentation of astrocyte and oligodendrocyte genes (both: adj p = 2.9E-04). (Fig.   S14 ). We observed a strong downregulation of oligodendrocyte genes and upregulation of microglia, neuron and astrocyte genes (Fig. 4A ). To investigate if these patterns are disease specific, we compared the log2 FC of genes differentially expressed (adj p < 0.05) with those non-differentially expressed (adj p ≥ 0.05) for each cell type. We observed the highest significance for oligodendrocyte (downregulated in MSA) and neuronal genes (upregulated in MSA) (p < 0.001). Similar results were obtained when we relaxed the gene inclusion cutoff to adj p < 0.10 ( Fig. S15) . We conducted GO enrichment analysis on the cell-specific DEGs. The highest significance was reached for oligodendrocyte genes, enriched for myelination and oligodendrocyte development processes. Astrocytes were enriched for transport of ion across the membrane, plasma membrane components, and ATPase complex (FDR < 0.01). Endothelial cell genes were enriched for cell migration and angiogenesis. Neuronal genes were enriched for neurogenesis and post-synapse organization ( Fig. 5 ; Table S12 ).
WGCNA analysis
Considering the large number of DEGs for the MSA-C subtype, we further investigated this group using WGCNA analysis. We computed a coexpression network using the data from C1 and validated the results in C2 by means of the module preservation analysis.
After filtering (see Methods), a network was generated using the 7,650 genes with larger MAD using "9" as threshold power (Fig. S16) . We obtained nine co-expression modules in total including 2,675 genes (35.0% of the genes), whereas the remaining were not significantly co-expressed and then were included in the grey module ( Tables S13 ranked by module membership p-value. The most important hubs for the 4 modules were: TGFB2 (yellow), SYNGAP1 (green), TIAM1 (brown) and QKI (blue). These networks are represented in Fig. 7 .
We conducted GO enrichment analysis and observed the most significant and specific enrichment in the brown and blue modules (Fig. S20 and Table S14 ). The yellow module (upregulated) showed a heterogeneous enrichment, including immune response but also tissue and organ development and response to stress. The green module We explored the enrichment for specific brain cell types gene expression using the data from [63] . Accordingly with the GO enrichment we observed, we found a significant enrichment of astrocyte (adj p = 3.3E-19) and endothelial genes (adj p = 2.8E-04) in the yellow module (upregulated, enriched for immunity and organ development), and a significant enrichment of neuronal genes (adj p = 2.5E-60) in the brown module (upregulated, enriched for synaptic processes). Furthermore, we detected a significant enrichment of oligodendrocyte genes (adj p = 7.7E-33) in the blue module (downregulated, enriched for myelination) (Fig. S21) .
We validated the results conducting module preservation analysis, using C2 as the test sample. We observed strong evidence of preservation for the blue (myelination) and brown (synapse) modules, and moderate evidence of preservation in the green module (translation). No evidence of preservation was detected for the yellow module (Fig. S22 ).
Discussion Overview
We conducted a genome-wide expression profiling study using cerebellar white matter (CWM) homogenates and LCM purified oligodendrocytes from MSA patients and healthy controls (HC). Two independent cohorts were analyzed using different expression profiling approaches and the differentially expressed genes were prioritized using meta-analysis techniques. WGCNA was applied to find clusters of genes functionally related and associated with the disease. This is the largest RNA profiling study conducted on post-mortem brain samples from MSA patients to date.
Differential dysregulation in MSA subtypes demonstrates more CWM transcriptional changes in MSA-C than in MSA-P After p-value combination, we obtained the largest number of DEGs in the MSA-C subgroup comparison (n = 747). Only one gene was noted to be differentially expressed in the MSA-P sub-type analysis. Of note, the majority of the MSA-P patients had demonstrable GCIs in the CWM and 35 DEGs were identified when the MSA cohort was utilized as a single group in a case/control analysis (MSA-C plus MSA-P vs. HC). Of note, the ratio of MSA-P:MSA-C was 2.6:1 therefore the decreased number of DEGs noted in the combined MSA analysis is likely due to the higher number of MSA-P patients in our study. These results agree with the larger involvement of CWM alterations in MSA-C compared to MSA-P during the early stages of the disease [18, 46] . It is possible that due to the early involvement of CWM in MSA-C there is a longer time for the disease-related transcriptional changes to develop in the CWM in these patients. [46] found more cerebellar and pontine involvement in MSA-C compared to MSA-P. suggesting that the observed downregulation of this gene in MSA might be regulated by changes in DNA methylation levels.
As mentioned in the Introduction, the relocalization of p25α from the myelin sheath to the oligodendrocyte soma is one of the earliest molecular events that may trigger α -synuclein aggregation. This process may also slow oligodendrocyte precursor cell maturation by the α -synuclein mediated downregulation of myelin-gene regulatory factor and myelin basic protein [34] . Interestingly, the gene coding for p25α (TPPP), which is expressed in oligodendrocytes, was detected to be significantly downregulated in MSA-C patients in our study (adj p < 0.05). Additionally, SNCA was significantly downregulated after p-value combination in MSA-C (adj p < 0.05). The same result was found in another study [30] , but not confirmed in other work [28, 42] . Other studies based on oligodendrocyte isolation and qPCA analysis described a basal expression and a trend of an increased expression in MSA patients [4, 19] .
Other relevant genes from the LCM study also associated with the myelination process were NF1, PLP1 and ERMN. NF1 Activating Protein 1, upregulated in MSA-C) which, like TIAM1, is also involved in synaptogenesis [7, 15] . The upregulation of neuron-specific genes and the enrichment for synaptogenesis is surprising in the context of a neurodegenerative disease like MSA.
Monomeric α-synuclein is normally located in the presynaptic nerve terminals and is involved in synaptogenesis [64, 65] . Perhaps, the enrichment of the synaptogenesis process in MSA-C CWM in our study might be a consequence of an abnormal accumulation of α-synuclein in the synapse of MSA patients. This elevated synaptic accumulation was previously described to precede the re-localization of α-synuclein from 
The importance of neuroinflammation in MSA-C
The combined relocalization of p25α and the ectopic presence of α -synuclein in oligodendrocytes are thought to trigger the formation of α -synuclein and p25α inclusions.
These inclusions and resulting oligodendrocyte dysfunction, activate microglia and astrocytes contributing to the neurodegenerative process through neuroinflammation (Fanciulli and Wenning, 2015) . These phenomena may explain our finding of the upregulated yellow module (314 genes). This module includes a large prevalence of astrocyte and microglia genes compared to the other significant modules and it is enriched for inflammatory and tissue/organ developmental processes. We found that astrocyte and endothelial specific genes were significantly upregulated in the DEGs from bulk tissue. The top hub gene in the yellow module was TGFB2 (Transforming Growth Factor Beta 2). This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins that are involved in the recruitment and activation of SMAD family transcription factors. Interestingly, the levels of TGFβ-2 were previously found to be increased in the neocortex of AD and dementia with Lewy bodies and were positively correlated with neuropathological markers of disease severity [14] .
This finding may suggest that TGF-beta is a key regulator of the inflammatory processes that may be more generalizable to neurodegenerative diseases regardless of the underlying causes and resulting neuropathologies. In the yellow module we found also MASP1 (log2 FC = 0.944; adj p 0.380), whose mRNA expression was found upregulated in a separate study conducted using frontal lobe post-mortem brains from MSA patients and controls [29] .
Collagen genes are upregulated in MSA
In the combined MSA group after p-value combination we detected 35 genes, most of them upregulated in patients. In both enrichment analyses we detected a key role of collagen genes: COL4A1, COL4A2, and ITGA11; all upregulated. COL4A1 (collagen type IV alpha 1 chain) and COL4A2 (collagen type IV alpha 1 chain) encode respectively for the alpha 1 and alpha 2 chains of type IV collagen which are important components of the basement membrane in all tissues, especially blood vessels. ITGA11 (Integrin Subunit Alpha 11) is functionally related as it is a collagen receptor. Mutations in COL4A1 and COL4A2 have been associated with sporadic brain small vessel disease [44] and porencephaly [10] . Recently Paiva et al., (2018) found COL4A2 upregulated in both A30P aSyn mice and dopaminergic neurons expressing A30P aSyn, suggesting a key role of collagen-related genes in α-synuclein induced toxicity. In the same study, they demonstrated a regulation of COL4A2 expression by miR-29a-3p, known to target COL4A4 mRNA. In a separate study the loss of miR-29a was correlated with increased levels of BACE1 and amyloid-β in sporadic Alzheimer's Disease [27] . Finally, lack of collagen VI has been related to neurodegeneration in mice models [11] , and its presence has been related to a neuroprotective role against β-Amyloid toxicity [13] .
Beside the collagen related pathway, the top genes detected in the differential expression analysis were: ACTN1 (Actinin Alpha 1), EMP1 (Epithelial Membrane Protein 1), and NFIL3 (Nuclear Factor, Interleukin 3 Regulated). Expression changes of ACTN1 were associated with AD in hippocampus [24], whereas NFIL3 was associated with neuroprotection in models of Amyotrophic Lateral Sclerosis [56] . EMP1 protein was also found upregulated in 5xFAD AD model [21] .
MSA-C shows a common transcriptional background with Alzheimer's Disease
We detected a large functional network in MSA-C patients that included APP and other AD-related genes that included PSEN1, CLU, ROCK2, EFNA1 and DYRK1. The module (M1) including these genes was enriched for amyloid-β metabolism. The strongest enrichment between MSA-C and AD DEGs was found in the temporal cortex and parahippocampal gyrus (AMP-AD data).
Study Limitations
We note some limitations of our study. First, MSA is a rare disease and although our cohort is the largest that has been expression profiled to date it is still likely that we are underpowered to detect small effect sizes that could be functionally important. Secondly, we acknowledge that the findings would be improved by the inclusion of additional brain regions that may be altered by the disease. For example, it isn't particularly surprising that we noted the most significant cerebellar transcriptional changes in MSA-C, a clinical subtype of MSA with predominating cerebellar symptoms. It would be interesting to compare the transcriptomic changes in the striatum, olivary nuclei, and pontine nuclei as well. Thirdly, we assessed C1 and C2 using different profiling approaches. This could be considered a positive aspect of our work as the identified transcriptional changes that cross-validate are likely not specific to a particular gene expression measurement approach and therefore may have higher reproducibility, however, this could also be considered a limitation as some true associations may be unreported due to their failure in one of the profiling chemistries and not due to the underlying biology. Lastly, layering additional genomic information -like DNA sequence information -would also enhance the study as it could facilitate more detailed analyses such as allele specific expression or epigenetic regulation of transcription.
Conclusions
This is the largest study ever conducted on the MSA brain transcriptome. We utilized two different cohorts that were each assessed by different gene expression analysis chemistries that we propose increases the robustness of DEG and co-expression network detection.
The 
